Form 4: PROCEPT BioRobotics CEO Reza Zadno Reports Stock Transactions

CEO Reza Zadno reports acquisition and disposal of PROCEPT BioRobotics Corp stock and stock options related to vesting RSUs and tax obligations.

Summary

• Reza Zadno, CEO of PROCEPT BioRobotics Corp, filed a Form 4 detailing changes in beneficial ownership.
• On March 6, 2024, Zadno acquired 54,933 shares of common stock through restricted stock units (RSUs) at $0.
• Also on March 6, 2024, Zadno sold 9,179 shares of common stock at a weighted average price of $46.67 to cover tax withholding obligations related to RSU vesting.
• Following these transactions, Zadno directly owns 246,710 shares of common stock.
• Zadno also acquired 47,849 stock options with an exercise price of $47.17, vesting monthly from March 5, 2024, over four years, expiring on March 5, 2034.
• Following these transactions, Zadno directly owns 47,849 stock options.

Sentiment

Score: 5

Explanation: The document reflects routine transactions related to executive compensation and tax obligations, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates transactions related to compensation and tax obligations, which are common occurrences.

Comparison to Industry Standards

• Insider transactions are common across publicly traded companies, particularly related to equity compensation plans.
• The vesting schedules and tax-related sales are standard practices in the industry.
• Comparable companies in the medical robotics space also utilize RSUs and stock options as part of their executive compensation packages.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares to cover tax obligations.
• The vesting of RSUs and stock options incentivizes the CEO to continue service with the company.

Key Dates